Abstract
Editorial: Improving cancer chemotherapy through pharmacogenomics: a research topic.
Highlights
Specialty section: This article was submitted to Pharmacogenetics and Pharmacogenomics, a section of the journal Frontiers in Genetics
It is well known that the efficacy and safety of chemotherapeutic drugs show substantial individual and/or population variability that can be explained, to a great extent, by genetic factors in pharmacokinetics and pharmacodynamics (Quiñones et al, 2008; Roco et al, 2012; Izar et al, 2013; Kessler et al, 2014; Patel, 2015; Unger et al, 2015)
Pharmacogenomics is an emerging field focused on genetic variations relevant to drug action (Evans and Relling, 2004; Maxmen, 2011; Mayer, 2014; Zhou et al, 2015)
Summary
Specialty section: This article was submitted to Pharmacogenetics and Pharmacogenomics, a section of the journal Frontiers in Genetics. Editorial: Improving cancer chemotherapy through pharmacogenomics: a research topic. It is well known that the efficacy and safety of chemotherapeutic drugs show substantial individual and/or population variability that can be explained, to a great extent, by genetic factors in pharmacokinetics and pharmacodynamics (Quiñones et al, 2008; Roco et al, 2012; Izar et al, 2013; Kessler et al, 2014; Patel, 2015; Unger et al, 2015).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
